| Financial Year |
March 31 2023 |
| Monetary Funds |
665,809,620.43 |
| Held-for-trading Financial Assets |
504,255,857.15 |
| Notes Receivable |
8,023,085.57 |
| Accounts Receivable |
65,023,106.70 |
| Advances to Suppliers |
24,769,863.16 |
| Other Receivables |
3,886,868.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
144,527,340.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
111,852,736.24 |
| Total Current Assets |
1,708,609,099.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
47,546,922.73 |
| Investment Properties |
334,893.59 |
| Fixed Assetes |
527,011,786.55 |
| Under-construction Projects |
140,397,618.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,817,346.16 |
| R&D expenses |
1,513,568.31 |
| Goodwill |
302,151,453.39 |
| Long-Term Deferred and Prepaid Expenses |
974,465.12 |
| Deferred Income Tax Assets |
83,422,666.24 |
| Other Non-Current Assets |
46,247,448.38 |
| Sub-Total of Non-Current Assets |
1,298,066,501.26 |
| Total Assets |
3,006,675,601.06 |
| Short-Term Loans |
30,032,625.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
60,540,036.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,903,371.12 |
| Taxes Payable |
7,089,605.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,155,247.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,781,642.78 |
| Other Current Liabilities |
1,369,685.21 |
| Sub-Total of Current Liabilities |
301,889,067.77 |
| Long-term Loans |
37,266,932.91 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,451,300.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,411,880.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,737,590.56 |
| Total Liabilities |
384,626,658.33 |
| Paid-In Capital(Or Share Stock) |
130,894,391.00 |
| Capital Surplus |
1,836,919,613.31 |
| Surplus Reserve |
53,264,178.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
576,427,888.50 |
| Minority Stockholder's Interest |
24,542,871.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,597,506,071.64 |
| Owner's Equity（Stockholder's Equity） |
2,622,048,942.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,006,675,601.06 |
